SG Americas Securities
MREO

SG Americas Securities’s Mereo BioPharma MREO Stock Holding History

SG Americas Securities’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Buy
+12,802
New +$3.84K ﹤0.01% 3316
2024
Q2 		– Sell
-16,221
Closed -$54K – 3134
2024
Q1 		$54K Buy
+16,221
New +$54.9K ﹤0.01% 2748

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SG Americas Securities's MREO Position: Q2 2026 in Review

SG Americas Securities opened a new position in Mereo BioPharma (MREO) in Q2 2026: 12,802 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #3316 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in MREO as recently as Q1 2024.

SG Americas Securities first reported a position in MREO in Q1 2024 and has held it in 2 quarters since. The position peaked at $54K in Q1 2024. 60 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • SG Americas Securities held 12,802 shares of Mereo BioPharma worth $4K as of Q2 2026.
  • Mereo BioPharma was a new SG Americas Securities position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3316 holding.
  • SG Americas Securities first reported a position in Mereo BioPharma in Q1 2024 and has held it in 2 quarters since.
  • SG Americas Securities's Mereo BioPharma position peaked at $54K in Q1 2024.
  • 60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.